373 related articles for article (PubMed ID: 10949196)
1. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
[TBL] [Abstract][Full Text] [Related]
2. Creation of chimeric hearts: a tool for testing the "passenger leukocyte" hypothesis.
Eiref SD; Zhang W; Popma SH; Shah LJ; Moore JS; Rosengard BR
Ann Thorac Surg; 1997 Sep; 64(3):628-33. PubMed ID: 9307449
[TBL] [Abstract][Full Text] [Related]
3. Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy.
Szeto WY; Krasinskas AM; Kreisel D; Krupnick AS; Popma SH; Rosengard BR
Transplantation; 2002 Apr; 73(7):1116-22. PubMed ID: 11965043
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
Mohiuddin MM; Qin Y; Qian X; Meng Y; DiSesa VJ
Ann Thorac Surg; 2001 Sep; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
[TBL] [Abstract][Full Text] [Related]
5. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
6. The role of passenger leukocyte genotype in rejection and acceptance of rat liver allografts.
Kreisel D; Petrowsky H; Krasinskas AM; Krupnick AS; Szeto WY; McLean AD; Popma SH; Gelman AE; Traum MK; Furth EE; Moore JS; Rosengard BR
Transplantation; 2002 May; 73(9):1501-7. PubMed ID: 12023631
[TBL] [Abstract][Full Text] [Related]
7. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
8. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
[TBL] [Abstract][Full Text] [Related]
9. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
[TBL] [Abstract][Full Text] [Related]
10. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
11. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.
Grazia TJ; Pietra BA; Johnson ZA; Kelly BP; Plenter RJ; Gill RG
J Immunol; 2004 Jun; 172(12):7451-8. PubMed ID: 15187123
[TBL] [Abstract][Full Text] [Related]
12. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism.
Shirwan H; Wu GD; Barwari L; Liu A; Cramer DV
Transplantation; 1997 Dec; 64(12):1671-6. PubMed ID: 9422400
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.
Kreisel D; Krasinskas AM; Krupnick AS; Gelman AE; Balsara KR; Popma SH; Riha M; Rosengard AM; Turka LA; Rosengard BR
J Immunol; 2004 Sep; 173(5):3027-34. PubMed ID: 15322162
[TBL] [Abstract][Full Text] [Related]
14. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
[TBL] [Abstract][Full Text] [Related]
16. Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries.
Qian Z; Hu W; Liu J; Sanfilippo F; Hruban RH; Baldwin WM
Transplantation; 2001 Sep; 72(5):900-6. PubMed ID: 11571457
[TBL] [Abstract][Full Text] [Related]
17. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
18. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
Pollak R; Blanchard JM
Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
[TBL] [Abstract][Full Text] [Related]
20. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
